Site Search

Back (see screen at page 12)

Store

Back (see screen at page 12)

About us

Back (see screen at page 12)

PwC Germany

Back (see screen at page 12)

Company Profile

Back (see screen at page 12)

The Territory Leadership Team

Back (see screen at page 12)

Organisational Structure

Back (see screen at page 12)

Analyst Relations

Back (see screen at page 12)

Newsletters

Back (see screen at page 12)

Ethics and Compliance: Information and Helpline

Back (see screen at page 12)

Locations

Back (see screen at page 12)

Berlin

Back (see screen at page 12)

Bielefeld

Back (see screen at page 12)

Bremen

Back (see screen at page 12)

Cologne

Back (see screen at page 12)

Düsseldorf

Back (see screen at page 12)

Erfurt

Back (see screen at page 12)

Essen

Back (see screen at page 12)

Frankfurt

Back (see screen at page 12)

Hamburg

Back (see screen at page 12)

Hanover

Back (see screen at page 12)

Kassel

Back (see screen at page 12)

Kiel

Back (see screen at page 12)

Leipzig

Back (see screen at page 12)

Mannheim

Back (see screen at page 12)

Munich

Back (see screen at page 12)

Nuremberg

Back (see screen at page 12)

Osnabrück

Back (see screen at page 12)

Saarbrücken

Back (see screen at page 12)

Schwerin

Back (see screen at page 12)

Stuttgart

Loading Results

Deal Announcement 03/14: Healthcare

PwC acted as the exclusive financial adviser to a consortium of noteholders on the sale of the Proton Therapy Center in Essen to Westdeutsches Protonentherapiezentrum Essen gGmbH, a subsidiary of the University Hospital of Essen

The Deal

An international PwC team consisting of senior M&A and BRS experts acted as exclusive financial adviser to an international consortium of banks on the sale of the Proton Therapy Center (PTC) in Essen to Westdeutsches Protonentherapiezentrum Essen gGmbH (WPE), a subsidiary of the University Hospital of Essen (UK Essen) and operator of the PTC. WPE will continue on as owner as well as operator of the PTC. Ion Beam Applications S.A. (IBA) will maintain the site at the highest standard possible.

The team advised the noteholders on their options and subsequently supported the implementation of a solution to secure the provision of this market leading treatment to cancer patients in the region.

Proton Therapy Center in Essen

The PTC is a provider of proton beam therapy to cancer patients. Proton beam therapy is a type of external-beam radiation treatment that uses protons to treat cancer. Advantages of the proton beam therapy are (amongst others) reduced collateral effects (less damage of healthy tissue, less cancer incidences from radiation).

PwC

A combined PwC M&A and BRS team in Germany and the United Kingdom acted as exclusive financial adviser to the (inter)national consortium of noteholders. PwC also provided Tax Advice and Financial Modelling Services (supported by experts from the PwC F&R team) to the noteholders.

PwC employs nearly 1.000 M&A professionals all over the world, realizing approximately 300 successful transactions per year. We specialize in a wide range of independent M&A services including advice on acquisitions and disposals, mergers, public takeovers, privatizations as well as structured financing.

The following PwC teams were involved:

Germany:
Alexander von Friesen (Partner M&A), Joachim Englert (Partner BRS), Daniel Keller (Partner Tax), Andreas Funke (Partner F&R), Thomas Gummert (Senior Manager F&R), Sandra Zölch (Senior Manager Tax), Godfried Hangx (Manager M&A).

United Kingdom:
Brian Lochead (Partner BRS) and Leo Smith (Senior Manager BRS).

Deal Announcement 03/14: Healthcare

Contact us

Dr. Alexander von Friesen

Dr. Alexander von Friesen

Partner, Corporate Finance | M&A Healthcare & Consumer, PwC Germany

Tel: +49 151 11714398

Linkedin Follow Email
Follow us
Offices Contact us

© 2017 - 2024 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.